Metrics to compare | 368A | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship368APeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.1x | 21.1x | −0.4x | |
PEG Ratio | 4.74 | −0.23 | 0.00 | |
Price/Book | 2.5x | 1.7x | 2.6x | |
Price / LTM Sales | 4.7x | 2.2x | 3.0x | |
Upside (Analyst Target) | - | 15.7% | 57.0% | |
Fair Value Upside | Unlock | 23.2% | 9.1% | Unlock |
Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company has strategic alliances with Repro Lifesciences LLP and establish a joint venture company in India for the purpose of strengthening regulatory compliance, market understanding, and customer support. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation operates as a subsidiary of Kitasato Shoji Co., Ltd.